Ampersand wins £22m five-year contract at London Zoo
June 25, 2012
The Purpose Advantage: An Anchor for Sustainable Business Growth
January 5, 2025
The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab ...